Celgene Switzerland and BMS-backed precision cancer drug developer Repare Therapeutics added $33m to its IPO after its shares rose 65% post-offering.
Month: June 2020
nCino enters IPO stage
The Salesforce-backed banking platform developer has filed for a $100m initial public offering having raised $80m late last year.
Microsoft snags CyberX in $165m acquisition
The IoT security technology provider had raised $48m in funding from investors including Qualcomm and Čez pre-acquisition.
Urjanet bills Equifax in series D round
Equifax was among the investors that provided $14.7m for the utility customer data provider to push its total funding past the $40m mark.
Foldax packs up $20m
MemorialCare Innovation Fund contributed to a series D round that brought the heart valve technology developer’s overall funding to more than $36m.
VisionNav lifts series B1 funding
Corporate venturing unit Lenovo Capital led a round that boosted smart forklift developer VisionNav’s funding total to more than $18m.
Keeping your wits about you in trucking
Daily leader from editor-in-chief James Mawson.
Invitae to inhale ArcherDX in $1.4bn deal
The Qiagen-founded precision cancer technology provider agreed to an acquisition by Invitae sized at at least $325m in cash and shares currently valued at about $820m.
Genetron jumps to public markets in $256m IPO
Vcanbio scored an exit as the precision cancer treatment and diagnostics developer went public in an upsized offering priced well above its range.
Poseida points the way to $115m IPO
Novartis is the second largest investor in the gene therapy developer, which has filed to go public less than a year after closing a $150m round.
Cedar sees its way to $102m
The series C round consisted of $77m in equity funding and $25m in venture debt, with Kaiser Permanente among the participants.
Surrozen scurries to $50m series C
Hartford Healthcare returned for a $50m series C round that will support the Stanford spinout in advancing potential treatments for severe liver and inflammatory bowel diseases.
Kutesmart measures out IPO intentions
The Fosun-backed smart apparel technology provider has filed to raise just over $50m on the Shenzhen Stock Exchange’s ChiNext market.
Big Health to grow with $39m
Kaiser Permanente Ventures and Samsung Next invested in the digital mental health treatment developer through a series B round that will fund product development and commercialisation.